The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Versican Plus BbPi IN nasal drops, lyophilisate and solvent for suspension for dogs

Zoetis Belgium S.A.VPA10387/098/001

Main Information

Trade NameVersican Plus BbPi IN nasal drops, lyophilisate and solvent for suspension for dogs
Active SubstancesBordetella bronchiseptica, live
Canine parainfluenza virus, live
Dosage FormLyophilisate and solvent for suspension for nasal administration
Licence HolderZoetis Belgium S.A.
License Holder Address2nd Floor, Building 10
Cherrywood Business Park, Loughlinstown
Co Dublin
Licence NumberVPA10387/098/001

Group Information

ATC CodeQI07AF01 bordetella + canine parainfluenza virus
Therapeutic ClassImmunological - Live Vaccine


License statusAuthorised
Licence Issued25/08/2020
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsPDF Version

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back